Literature DB >> 22425530

The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study.

Joseph C Ratliff1, Laura B Palmese, Erin L Reutenauer, Ellen Liskov, Carlos M Grilo, Cenk Tek.   

Abstract

OBJECTIVE: With the rate of obesity on the rise worldwide, individuals with schizophrenia represent a particularly vulnerable population. The aim of this study was to assess the metabolic profile of individuals with schizophrenia in relation to dietary and physical activity habits compared with healthy controls.
METHODS: Dietary and physical activity habits of 130 individuals with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition diagnosis of schizophrenia or schizoaffective disorder were compared with 250 body mass index-, age-, and sex-matched and racially matched controls from the 2005-2008 National Health and Nutrition Examination Surveys using a 24-hour diet recall and a self-report physical activity questionnaire.
RESULTS: Individuals with schizophrenia had significantly higher levels of glycosylated hemoglobin and insulin compared with matched controls. In addition, these individuals had an increased waist circumference and diastolic blood pressure than did the comparison group. Daily energy intake was not different between groups; however, individuals with schizophrenia consumed significantly greater amounts of sugar and fat. Individuals with schizophrenia reported engaging in moderate physical activity less frequently compared with the National Health and Nutrition Examination Surveys group, but there was no difference in reported vigorous physical activity.
CONCLUSIONS: These findings suggest that the dietary and physical activity habits of individuals with schizophrenia contribute to an adverse metabolic profile. Increased opportunities for physical activity and access to healthy foods for individuals with schizophrenia may ease the burden of disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425530      PMCID: PMC3380150          DOI: 10.1016/j.comppsych.2012.02.003

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  34 in total

1.  The relationship between exercise performance and peripheral circulation in patients with peripheral arterial occlusive disease.

Authors:  S Y Chen; Y T Wu; S S Wang
Journal:  Angiology       Date:  2001-04       Impact factor: 3.619

2.  The distribution of body mass index among individuals with and without schizophrenia.

Authors:  D B Allison; K R Fontaine; M Heo; J L Mentore; J C Cappelleri; L P Chandler; P J Weiden; L J Cheskin
Journal:  J Clin Psychiatry       Date:  1999-04       Impact factor: 4.384

3.  Dietary methodology considerations for NHANES III.

Authors:  L Kohlmeier
Journal:  Vital Health Stat 4       Date:  1992-03

4.  Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia.

Authors:  Davy Vancampfort; Michel Probst; Thomas Scheewe; Katrien Maurissen; Kim Sweers; Jan Knapen; Marc De Hert
Journal:  Schizophr Res       Date:  2011-04-14       Impact factor: 4.939

5.  A simple method to assess exercise behavior in the community.

Authors:  G Godin; R J Shephard
Journal:  Can J Appl Sport Sci       Date:  1985-09

6.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

7.  Association of the metabolic syndrome with physical activity performance in patients with schizophrenia.

Authors:  D Vancampfort; K Sweers; M Probst; K Maurissen; J Knapen; P Minguet; M De Hert
Journal:  Diabetes Metab       Date:  2011-03-09       Impact factor: 6.041

8.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

9.  Nutritional assessment of patients with schizophrenia: a preliminary study.

Authors:  Martin Strassnig; Jaspreet Singh Brar; Rohan Ganguli
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 10.  Atypical antipsychotics and glucose dysregulation: a systematic review.

Authors:  Hua Jin; Jonathan M Meyer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

View more
  19 in total

Review 1.  Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-07-15       Impact factor: 3.911

2.  Treatment response to the RENEW weight loss intervention in schizophrenia: impact of intervention setting.

Authors:  Catana Brown; Jeannine Goetz; Edna Hamera; Byron Gajewski
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

3.  Cardiovascular mortality in schizophrenia: defining a critical period for prevention.

Authors:  Vinod H Srihari; Vivek H Phutane; Banu Ozkan; Lydia Chwastiak; Joseph C Ratliff; Scott W Woods; Cenk Tek
Journal:  Schizophr Res       Date:  2013-02-17       Impact factor: 4.939

Review 4.  An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologists.

Authors:  Aniyizhai Annamalai; Cenk Tek
Journal:  Int J Endocrinol       Date:  2015-03-23       Impact factor: 3.257

5.  Dietary patterns and schizophrenia: a comparison with healthy controls.

Authors:  Koji Tsuruga; Norio Sugawara; Yasushi Sato; Manabu Saito; Hanako Furukori; Taku Nakagami; Kazuhiko Nakamura; Ippei Takahashi; Shigeyuki Nakaji; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-22       Impact factor: 2.570

6.  Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.

Authors:  Cenk Tek; Sinan Guloksuz; Vinod H Srihari; Erin L Reutenauer
Journal:  BMC Psychiatry       Date:  2013-06-27       Impact factor: 3.630

7.  The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia.

Authors:  Po-Sheng Wang; Shang-Liang Wu; Han-Yi Ching
Journal:  Int Clin Psychopharmacol       Date:  2014-07       Impact factor: 1.659

8.  Attitudes toward metabolic adverse events among patients with schizophrenia in Japan.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Manabu Yamazaki; Kazutaka Shimoda; Takao Mori; Takuro Sugai; Hiroshi Matsuda; Yutaro Suzuki; Yoshitake Minami; Yuji Ozeki; Kurefu Okamoto; Toyoaki Sagae; Toshiyuki Someya
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-24       Impact factor: 2.570

9.  Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia.

Authors:  Pedro Caldana Gordon; Josefa Cynara Xavier; Mario Rodrigues Louzã
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-17       Impact factor: 2.570

Review 10.  Dysfunction in the coagulation system and schizophrenia.

Authors:  S Hoirisch-Clapauch; O B Amaral; M A U Mezzasalma; R Panizzutti; A E Nardi
Journal:  Transl Psychiatry       Date:  2016-01-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.